文献速递糖尿病

葡萄糖衍生个体化HbA1c校正研究改善CGM指标与HbA1c一致性

Glucose-Derived Personalized HbA1c Correction (GDAC) Study to Improve Alignment Between CGM-Derived Metrics and HbA1c in Different Individuals and Racial Groups With Diabetes: Implications for Clinical Practice.
PubMed 文献 · Diabetes Care · 2026-01-01

该前瞻性研究纳入257例1型或2型糖尿病患者,涵盖四个种族群体,通过计算个体糖化比率(PGR)推导个体化HbA1c(pA1C)。结果显示33%患者存在≥0.5%的HbA1c与平均血糖不一致,黑人群体最高(41%),使用pA1C后总体不一致率降至14%,黑人群体降至12%。

要点

  • HbA1c与平均血糖不一致在糖尿病患者中常见,黑人群体更显著。
  • 基于个体糖化比率计算的pA1C可显著减少不一致。
  • pA1C可能有助于优化临床管理并减少健康差异。

核心结论

  • HbA1c与平均血糖不一致常见,尤其在黑人群体中,pA1C改善与血糖水平的一致性,可能有助于优化临床管理并减少健康差异。

研究设计与样本

  • 26周前瞻性研究,纳入257例1型或2型糖尿病患者,涵盖四个种族群体,每2周收集HbA1c并全程使用CGM,利用0-12周数据推导PGR,20-26周验证pA1C。

主要发现

  • 总体33%患者存在≥0.5%的HbA1c-AG不一致,黑人群体为41%。
  • 使用pA1C后总体不一致率降至14%(降低58%),黑人群体降至12%(降低71%)。

关键数值与推荐

  • 临床有意义的不一致定义为≥0.5%。
  • PGR由HbA1c和AG数据(0-12周)推导,用于计算pA1C。

临床怎么用

  • 对于HbA1c与CGM平均血糖不一致的患者,可考虑使用pA1C校正以更准确反映血糖暴露。

局限性

  • 研究仅纳入1型或2型糖尿病患者,样本量为257例,需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Glycated hemoglobin (HbA1c) and average glucose (AG) can show discordance due to personal variations in red blood cell (RBC) physiology, creating management difficulties. Our aims were to understand the size of the problem and refine this glycemic metric by adjusting for personal differences in RBC characteristics. RESEARCH AND DESIGN AND METHODS: A 26-week prospective study was conducted in individuals with type 1 diabetes (T1D) or type 2 diabetes across four racial groups with HbA1c collected every 2 weeks and continuous glucose monitoring (CGM) used throughout. Personal glycation ratio (PGR) was derived from HbA1c and AG data (weeks 0-12), allowing calculation of personalized HbA1c (pA1C) and subsequent testing (weeks 20-26). The relationship between AG and HbA1c or pA1C was then analyzed, documenting a clinically meaningful discordance of ≥0.5%. In addition, we used real-world data sets to further validate the accuracy of pA1C at reflecting glucose exposure. RESULTS: Of 257 participants (19% T1D) with complete CGM and HbA1c data sets, mean age (±SD) was 53 ± 14 years (45% females). The racial background was 35% Asian, 30% White, 22% Black, and 14% other/mixed. Of the total study population, 33% showed ≥0.5% HbA1c-AG discordance, with the Black population affected most (41% discordance). Use of pA1C reduced the discordance in the whole population to 14% (58% reduction), while this was reduced in the Black population to 12% (71% reduction). CONCLUSIONS: HbA1c-AG discordance is common, particularly in the Black population, with pA1C improving alignment with glucose levels, potentially helping to optimize clinical management and reduce health disparities.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Ajjan RA, Choudhary P, Xu Y, et al. Glucose-Derived Personalized HbA1c Correction (GDAC) Study to Improve Alignment Between CGM-Derived Metrics and HbA1c in Different Individuals and Racial Groups With Diabetes: Implications for Clinical Practice. Diabetes Care. 2026. PMID: 42257619. doi:10.2337/dc26-0398

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。